Applied DNA Sciences
Applied DNA Sciences
APDN
NASDAQ
0.06
USD
0.00%
About
Applied DNA Sciences, Inc. is a biotechnology company that develops, and markets deoxyribonucleic acid (DNA) based technology solutions. The Company is utilizing its LinearDNA large-scale polymerase chain reaction (PCR) based manufacturing platform. The Company’s proprietary platform produces large quantities of DNA for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets and for supply chain security, anti-counterfeiting and anti-theft technology purposes.
It also develops PCR-based molecular in vitro diagnostics for covid-19. In addition, under its wholly owned subsidiary, Applied DNA Clinical Labs, LLC, the Company is offering a high-throughput turnkey solution for population-scale Covid-19 testing marketed as safeCircle. safeCircle utilizes the Company’s Covid-19 Diagnostic Tests and is designed to look for infection within defined populations or communities utilizing high throughput testing methodologies..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 45.9M |
| Three Month Average Volume | 196.3M |
| High Low | |
| Fifty-Two Week High | 28.4 USD |
| Fifty-Two Week Low | 0.3131 USD |
| Fifty-Two Week High Date | 15 Sep 2023 |
| Fifty-Two Week Low Date | 14 Aug 2024 |
| Price and Volume | |
| Current Price | 1.91 USD |
| Beta | 0 |
| Relative Price Change | |
| Four Week Relative Price Change | 380.07% |
| Thirteen Week Relative Price Change | 199.53% |
| Twenty-Six Week Relative Price Change | -84.49% |
| Fifty-Two Week Relative Price Change | -94.05% |
| Year-to-Date Relative Price Change | -86.93% |
| Price Change | |
| One Day Price Change | -13.57% |
| Thirteen Week Price Change | 220.58% |
| Twenty-Six Week Price Change | -82.95% |
| Five Day Price Change | -24.80% |
| Fifty-Two Week Price Change | -92.54% |
| Year-to-Date Price Change | -84.52% |
| Month-to-Date Price Change | 407.98% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 7.24988 USD |
| Book Value Per Share (Most Recent Quarter) | 1.20318 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 3.29782 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.94113 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -8.94691 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 20.4467 USD |
| Revenue Per Share (Trailing Twelve Months) | 2.17543 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -15.2149 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -11.86288 USD |
| Normalized (Last Fiscal Year) | -15.2149 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -15.2149 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -11.86288 USD |
| Including Extraordinary Items (Last Fiscal Year) | -15.2149 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -11.86288 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 10.47223 USD |
| Cash Per Share (Most Recent Quarter) | 1.01386 USD |
| Cash Flow Per Share (Last Fiscal Year) | -13.24727 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -4.12358 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -9.10759 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -108 |
| Cash Flow Revenue (Trailing Twelve Months) | -419 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -217.48% |
| Pretax Margin (Last Fiscal Year) | -74.98% |
| Pretax Margin (5 Year) | -113.23% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 41.39% |
| Gross Margin (Trailing Twelve Months) | 25.04% |
| Gross Margin (5 Year) | 44.35% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -81.94% |
| Operating Margin (Trailing Twelve Months) | -439.20% |
| Operating Margin (5 Year) | -129.25% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -74.98% |
| Net Profit Margin (Trailing Twelve Months) | -217.48% |
| Net Profit Margin (5 Year) | -113.26% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -18.40% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | -72.66% |
| Revenue Growth (3 Year) | 27.92% |
| Revenue Change (Trailing Twelve Months) | -78.96% |
| Revenue Per Share Growth | -28.03% |
| Revenue Growth (5 Year) | 90.57% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | 33.80% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 109.75% |
| EPS Change (Trailing Twelve Months) | -7.67% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 9 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -10,442,130 |
| Net Debt (Last Fiscal Year) | -7,151,800 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 1 |
| Price to Sales (Trailing Twelve Months) | 6 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 0 |
| Price to Book (Most Recent Quarter) | 2 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 3 |
| Quick Ratio (Most Recent Quarter) | 4 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 3 |
| Current Ratio (Most Recent Quarter) | 4 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -7,358,490 |
| Free Cash Flow (Trailing Twelve Months) | -14,226,190 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -55.81% |
| Return on Assets (Trailing Twelve Months) | -45.51% |
| Return on Assets (5 Year) | -88.57% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -111.37% |
| Return on Equity (Trailing Twelve Months) | -76.58% |
| Return on Equity (5 Year) | -171.86% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -69.20% |
| Return on Investment (Trailing Twelve Months) | -55.20% |
| Return on Investment (5 Year) | -121.91% |